Nancy Krieger1, Jaquelyn L Jahn2, Pamela D Waterman2. 1. Department of Social and Behavioral Sciences (SBS), Harvard T.H. Chan School of Public Health (HSPH), 677 Huntington Avenue, Boston, MA, 02115, USA. nkrieger@hsph.harvard.edu. 2. Department of Social and Behavioral Sciences (SBS), Harvard T.H. Chan School of Public Health (HSPH), 677 Huntington Avenue, Boston, MA, 02115, USA.
Abstract
PURPOSE: It is unknown whether Jim Crow-i.e., legal racial discrimination practiced by 21 US states and the District of Columbia and outlawed by the US Civil Rights Act in 1964-affects US cancer outcomes. We hypothesized that Jim Crow birthplace would be associated with higher risk of estrogen-receptor-negative (ER-) breast tumors among US black, but not white, women and also a higher black versus white risk for ER- tumors. METHODS: We analyzed data from the SEER 13 registry group (excluding Alaska) for 47,157 US-born black non-Hispanic and 348,514 US-born white non-Hispanic women, aged 25-84 inclusive, diagnosed with primary invasive breast cancer between 1 January 1992 and 31 December 2012. RESULTS: Jim Crow birthplace was associated with increased odds of ER- breast cancer only among the black, not white women, with the effect strongest for women born before 1965. Among black women, the odds ratio (OR) for an ER- tumor, comparing women born in a Jim Crow versus not Jim Crow state, equaled 1.09 (95% confidence interval [CI] 1.06, 1.13), on par with the OR comparing women in the worst versus best census tract socioeconomic quintiles (1.15; 95% CI 1.07, 1.23). The black versus white OR for ER- was higher among women born in Jim Crow versus non-Jim Crow states (1.41 [95% CI 1.13, 1.46] vs. 1.27 [95% CI 1.24, 1.31]). CONCLUSIONS: The unique Jim Crow effect for US black women for breast cancer ER status underscores why analysis of racial/ethnic inequities must be historically contextualized.
PURPOSE: It is unknown whether Jim Crow-i.e., legal racial discrimination practiced by 21 US states and the District of Columbia and outlawed by the US Civil Rights Act in 1964-affects US cancer outcomes. We hypothesized that Jim Crow birthplace would be associated with higher risk of estrogen-receptor-negative (ER-) breast tumors among US black, but not white, women and also a higher black versus white risk for ER- tumors. METHODS: We analyzed data from the SEER 13 registry group (excluding Alaska) for 47,157 US-born black non-Hispanic and 348,514 US-born white non-Hispanic women, aged 25-84 inclusive, diagnosed with primary invasive breast cancer between 1 January 1992 and 31 December 2012. RESULTS: Jim Crow birthplace was associated with increased odds of ER- breast cancer only among the black, not white women, with the effect strongest for women born before 1965. Among black women, the odds ratio (OR) for an ER- tumor, comparing women born in a Jim Crow versus not Jim Crow state, equaled 1.09 (95% confidence interval [CI] 1.06, 1.13), on par with the OR comparing women in the worst versus best census tract socioeconomic quintiles (1.15; 95% CI 1.07, 1.23). The black versus white OR for ER- was higher among women born in Jim Crow versus non-Jim Crow states (1.41 [95% CI 1.13, 1.46] vs. 1.27 [95% CI 1.24, 1.31]). CONCLUSIONS: The unique Jim Crow effect for US black women for breast cancer ER status underscores why analysis of racial/ethnic inequities must be historically contextualized.
Entities:
Keywords:
Black Americans; Breast cancer estrogen receptor; Health inequities; Jim Crow; Racial disparities; Segregation
Authors: J C Chen; Yaming Li; James L Fisher; Oindrila Bhattacharyya; Allan Tsung; Jose G Bazan; Samilia Obeng-Gyasi Journal: Ann Surg Oncol Date: 2022-06-08 Impact factor: 4.339
Authors: Brittny C Davis Lynn; Pavel Chernyavskiy; Gretchen L Gierach; Philip S Rosenberg Journal: J Natl Cancer Inst Date: 2022-09-09 Impact factor: 11.816
Authors: Jayne O Ifekwunigwe; Jennifer K Wagner; Joon-Ho Yu; Tanya M Harrell; Michael J Bamshad; Charmaine D Royal Journal: Am Anthropol Date: 2017-08-14
Authors: Alexander P Cole; Peter Herzog; Hari S Iyer; Maya Marchese; Brandon A Mahal; Stuart R Lipsitz; Joshua Nyambose; Susan T Gershman; Mark Kennedy; Gail Merriam; Timothy R Rebbeck; Quoc-Dien Trinh Journal: Cancer Date: 2021-05-17 Impact factor: 6.921
Authors: Madina Agénor; Carly Perkins; Catherine Stamoulis; Rahsaan D Hall; Mihail Samnaliev; Stephanie Berland; S Bryn Austin Journal: Public Health Rep Date: 2021-02-22 Impact factor: 3.117